Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,200
Closed -$4K 4432
2022
Q4
$4K Sell
1,200
-1,700
-59% -$2.65K ﹤0.01% 3338
2022
Q3
$9K Sell
2,900
-5,000
-63% -$12.4K ﹤0.01% 3205
2022
Q2
$15K Sell
7,900
-35,900
-82% -$85.9K ﹤0.01% 2910
2022
Q1
$220K Buy
43,800
+11,700
+36% +$41.1K 0.01% 1132
2021
Q4
$170K Buy
32,100
+25,100
+359% +$190K 0.01% 1454
2021
Q3
$3K Sell
7,000
-26,700
-79% -$196K ﹤0.01% 4832
2021
Q2
$46K Buy
33,700
+26,000
+338% +$219K ﹤0.01% 2546
2021
Q1
$12K Buy
+7,700
New +$51.2K ﹤0.01% 3659

Other funds holding OCGN

Cutler Group's OCGN Position: Q1 2023 in Review

Cutler Group sold out of Ocugen (OCGN) in Q1 2023, closing a stake of 3,500 shares — an estimated $4K sold.

Cutler Group first reported a position in OCGN in Q1 2021 and held it in 8 quarters. The position peaked at $63K in Q1 2021. 103 funds tracked by Wall St. Rank hold OCGN as of Q1 2023.

  • Cutler Group reported no remaining Ocugen position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 3,500 Ocugen shares in Q1 2023, an estimated $4K.
  • Cutler Group first reported a position in Ocugen in Q1 2021 and held it in 8 quarters.
  • Cutler Group's Ocugen position peaked at $63K in Q1 2021.
  • 103 funds tracked by Wall St. Rank held Ocugen as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.